BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Feng S, De Carvalho DD. Clinical advances in targeting epigenetics for cancer therapy. FEBS J. [DOI: 10.1111/febs.15750] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Chava S, Bugide S, Malvi P, Gupta R. Co-targeting of specific epigenetic regulators in combination with CDC7 potently inhibit melanoma growth. iScience 2022;25:104752. [DOI: 10.1016/j.isci.2022.104752] [Reference Citation Analysis]
2 Zhao L, Guo H, Chen X, Zhang W, He Q, Ding L, Yang B. Tackling drug resistance in ovarian cancer with epigenetic targeted drugs. Eur J Pharmacol 2022;927:175071. [PMID: 35636522 DOI: 10.1016/j.ejphar.2022.175071] [Reference Citation Analysis]
3 Dai E, Zhu Z, Wahed S, Qu Z, Storkus WJ, Guo ZS. Epigenetic modulation of antitumor immunity for improved cancer immunotherapy. Mol Cancer 2021;20. [DOI: 10.1186/s12943-021-01464-x] [Reference Citation Analysis]
4 Farhana A, Koh AE, Ling Mok P, Alsrhani A, Khan YS, Subbiah SK. Camptothecin Encapsulated in β-Cyclodextrin-EDTA-Fe3O4 Nanoparticles Induce Metabolic Reprogramming Repair in HT29 Cancer Cells through Epigenetic Modulation: A Bioinformatics Approach. Nanomaterials (Basel) 2021;11:3163. [PMID: 34947512 DOI: 10.3390/nano11123163] [Reference Citation Analysis]
5 Gimeno-Valiente F, Riffo-Campos ÁL, Torres L, Tarazona N, Gambardella V, Cervantes A, López-Rodas G, Franco L, Castillo J. Epigenetic Mechanisms Are Involved in the Oncogenic Properties of ZNF518B in Colorectal Cancer. Cancers (Basel) 2021;13:1433. [PMID: 33801071 DOI: 10.3390/cancers13061433] [Reference Citation Analysis]
6 Southekal S, Mishra NK, Guda C. Pan-Cancer Analysis of Human Kinome Gene Expression and Promoter DNA Methylation Identifies Dark Kinase Biomarkers in Multiple Cancers. Cancers (Basel) 2021;13:1189. [PMID: 33801837 DOI: 10.3390/cancers13061189] [Reference Citation Analysis]
7 Dong J, Pervaiz W, Tayyab B, Li D, Kang L, Zhang H, Gong H, Ma X, Li J, Agboyibor C, Bi Y, Liu H. A comprehensive comparative study on LSD1 in different cancers and tumor specific LSD1 inhibitors. Eur J Med Chem 2022;240:114564. [PMID: 35820351 DOI: 10.1016/j.ejmech.2022.114564] [Reference Citation Analysis]
8 El Omari N, Bakha M, Imtara H, Guaouguaoua FE, Balahbib A, Zengin G, Bouyahya A. Anticancer mechanisms of phytochemical compounds: focusing on epigenetic targets. Environ Sci Pollut Res Int 2021;28:47869-903. [PMID: 34308524 DOI: 10.1007/s11356-021-15594-8] [Reference Citation Analysis]
9 Chaves LP, Melo CM, Saggioro FP, Reis RBD, Squire JA. Epithelial–Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics. Genes 2021;12:1900. [DOI: 10.3390/genes12121900] [Reference Citation Analysis]
10 Dey A, Kundu M, Das S, Jena BC, Mandal M. Understanding the function and regulation of Sox2 for its therapeutic potential in breast cancer. Biochim Biophys Acta Rev Cancer 2022;:188692. [PMID: 35122882 DOI: 10.1016/j.bbcan.2022.188692] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]